Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jul-22 5:00 PM View:  | Protara Therapeutics, Inc. (TARA) | 30-Jun-22 | Private Purchase | 10,000 | $3.10 | $31,000.00 | 5% 188.0K to 198.0K | |
| 16-Mar-22 4:37 PM View: | Protara Therapeutics, Inc. (TARA) | 14-Mar-22 | Private Purchase | 10,000 | $4.25 | $42,500.00 | 6% 178.0K to 188.0K | |
| 14-Mar-22 4:37 PM View: | Protara Therapeutics, Inc. (TARA) | 10-Mar-22 | Private Purchase | 10,000 | $4.46 | $44,555.00 | 6% 168.0K to 178.0K | |
| 13-Jan-20 6:56 PM View: | Protara Therapeutics, Inc. (TARA) | 10-Jan-20 | Grant | 168,000 | -- | -- | 100% 0 to 168.0K | |
| 03-Dec-18 4:19 PM View: | Regenxbio Inc. (RGNX) | 29-Nov-18 | Option Exercise | 12,784 | $3.76 | $48,067.80 | 100% 0 to 12.78K | |
| 03-Dec-18 4:19 PM View: | Regenxbio Inc. (RGNX) | 29-Nov-18 | Market Option Sale (Planned) | 12,784 | $65.00 | $830,960.00 | (100%) 12.78K to 0 | 25% |
| 28-Nov-18 4:20 PM View: | Regenxbio Inc. (RGNX) | 27-Nov-18 | Option Exercise | 18,786 | $18.47 | $346,908.00 | 100% 0 to 18.79K | |
| 28-Nov-18 4:20 PM View: | Regenxbio Inc. (RGNX) | 27-Nov-18 | Market Option Sale (Planned) | 18,786 | $65.03 | $1,221,650.00 | (100%) 18.79K to 0 | 25% |
| 28-Nov-18 4:20 PM View: | Regenxbio Inc. (RGNX) | 26-Nov-18 | Option Exercise | 1,721 | $49.45 | $85,103.50 | 100% 0 to 1.72K | |
| 28-Nov-18 4:20 PM View: | Regenxbio Inc. (RGNX) | 26-Nov-18 | Market Option Sale (Planned) | 1,721 | $65.00 | $111,865.00 | (100%) 1.72K to 0 | 25% |
| 21-Nov-18 4:26 PM View: | Regenxbio Inc. (RGNX) | 20-Nov-18 | Option Exercise | 21,176 | $9.07 | $191,963.00 | 100% 0 to 21.18K | |
| 21-Nov-18 4:26 PM View: | Regenxbio Inc. (RGNX) | 20-Nov-18 | Market Option Sale (Planned) | 21,176 | $60.38 | $1,278,610.00 | (100%) 21.18K to 0 | 19% |
| 21-Nov-18 4:26 PM View: | Regenxbio Inc. (RGNX) | 19-Nov-18 | Option Exercise | 12,116 | $23.78 | $288,138.00 | 100% 0 to 12.12K | |
| 21-Nov-18 4:26 PM View: | Regenxbio Inc. (RGNX) | 19-Nov-18 | Market Option Sale (Planned) | 12,116 | $60.55 | $733,602.00 | (100%) 12.12K to 0 | 20% |
| 24-Feb-15 9:14 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 21-Feb-15 | Disposition (change in control) | 75,201 | $46.00 | $3,459,250.00 | (100%) 75.2K to 0 | |
| 20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 17-Feb-15 | Option Exercise | 7,422 | $11.71 | $86,899.90 | 11% 67.78K to 75.2K | |
| 20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-15 | Payment of Exercise | 4,789 | $45.88 | $219,719.00 | (7%) 72.57K to 67.78K | |
| 20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-15 | Option Exercise | 10,531 | -- | -- | 17% 62.04K to 72.57K | |
| 20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 12-Feb-15 | Payment of Exercise | 1,427 | $45.85 | $65,427.90 | (2%) 63.46K to 62.04K | |
| 20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 12-Feb-15 | Option Exercise | 3,832 | -- | -- | 6% 59.63K to 63.46K | |
| 20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-15 | Payment of Exercise | 3,148 | $45.85 | $144,336.00 | (5%) 62.78K to 59.63K | |
| 20-Feb-15 4:46 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-15 | Acquisition (other) | 8,967 | -- | -- | 17% 53.81K to 62.78K | |
| 09-Feb-15 5:35 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 06-Feb-15 | Gift | 10,000 | -- | -- | (14%) 72.78K to 62.78K | |
| 19-Dec-14 10:23 AM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 17-Dec-14 | Option Exercise | 52,258 | $7.15 | $373,670.00 | 72% 72.78K to 125.04K | |
| 19-Dec-14 10:23 AM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 17-Dec-14 | Planned Private Option Sale | 52,258 | $35.00 | $1,829,030.00 | (42%) 125.04K to 72.78K | |
| 19-Nov-14 7:23 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 17-Nov-14 | Option Exercise | 47,442 | $4.71 | $223,564.00 | 65% 72.78K to 120.22K | |
| 19-Nov-14 7:23 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 17-Nov-14 | Market Option Sale (Planned) | 47,442 | $30.01 | $1,423,640.00 | (39%) 120.22K to 72.78K | 2% |
| 04-Nov-14 3:53 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 31-Oct-14 | Market Sale (Planned) | 10,000 | $29.00 | $290,000.00 | (12%) 82.78K to 72.78K | 6% |
| 29-Oct-14 11:58 AM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 27-Oct-14 | Market Sale (Planned) | 30,635 | $26.75 | $819,606.00 | (27%) 113.42K to 82.78K | (5%) |
| 15-Aug-14 4:11 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Aug-14 | Option Exercise | 53,813 | $3.45 | $185,915.00 | 90% 59.6K to 113.42K | |
| 14-Feb-14 8:40 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-14 | Payment of Exercise | 5,459 | $38.30 | $209,080.00 | (8%) 65.06K to 59.6K | 29% |
| 14-Feb-14 8:40 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 13-Feb-14 | Option Exercise | 10,530 | -- | -- | 19% 54.53K to 65.06K | |
| 11-Feb-14 4:13 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-14 | Payment of Exercise | 4,649 | $35.13 | $163,319.00 | (8%) 59.18K to 54.53K | 23% |
| 11-Feb-14 4:13 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 07-Feb-14 | Acquisition (other) | 8,967 | -- | -- | 18% 50.21K to 59.18K | |
| 09-Jan-14 4:53 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 08-Jan-14 | Option Exercise | 31,588 | $3.34 | $105,504.00 | 53% 59.18K to 90.77K | |
| 09-Jan-14 4:53 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 08-Jan-14 | Market Option Sale (Planned) | 31,588 | $35.01 | $1,105,900.00 | (35%) 90.77K to 59.18K | 23% |
| 30-Dec-13 5:30 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 26-Dec-13 | Option Exercise | 37,874 | $5.17 | $195,822.00 | 64% 59.18K to 97.05K | |
| 30-Dec-13 5:30 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 26-Dec-13 | Market Option Sale (Planned) | 37,874 | $30.02 | $1,136,980.00 | (39%) 97.05K to 59.18K | 10% |
| 16-Dec-13 6:11 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 12-Dec-13 | Option Exercise | 60,311 | $8.24 | $496,734.00 | 102% 59.18K to 119.49K | |
| 16-Dec-13 6:11 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 12-Dec-13 | Market Option Sale (Planned) | 60,311 | $24.02 | $1,448,390.00 | (50%) 119.49K to 59.18K | (13%) |
| 24-Sep-13 4:30 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 20-Sep-13 | Option Exercise | 50,000 | $5.72 | $286,200.00 | 41% 123.36K to 173.36K | |
| 24-Sep-13 4:30 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 20-Sep-13 | Market Option Sale (Planned) | 50,000 | $30.26 | $1,512,880.00 | (29%) 173.36K to 123.36K | 10% |
| 17-Sep-13 5:19 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 16-Sep-13 | Option Exercise | 50,000 | $4.05 | $202,500.00 | 30% 168.36K to 218.36K | |
| 17-Sep-13 5:19 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 16-Sep-13 | Market Option Sale (Planned) | 50,000 | $27.89 | $1,394,580.00 | (23%) 218.36K to 168.36K | 3% |
| 13-May-13 4:24 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 09-May-13 | Option Exercise | 45,150 | $4.05 | $182,858.00 | 28% 163.51K to 208.66K | |
| 13-May-13 4:24 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 09-May-13 | Market Option Sale (Planned) | 45,150 | $14.18 | $640,001.00 | (22%) 208.66K to 163.51K | (91%) |
| 01-May-13 5:22 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 29-Apr-13 | Option Exercise | 4,850 | $4.05 | $19,642.50 | 8% 59.18K to 64.03K | |
| 01-May-13 5:22 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 29-Apr-13 | Market Option Sale (Planned) | 4,850 | $14.00 | $67,900.00 | (8%) 64.03K to 59.18K | (94%) |
| 10-Apr-13 6:19 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 10-Apr-13 | Option Exercise | 50,000 | $4.05 | $202,500.00 | 84% 59.18K to 109.18K | |
| 10-Apr-13 6:19 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 10-Apr-13 | Market Option Sale (Planned) | 50,000 | $12.00 | $600,220.00 | (46%) 109.18K to 59.18K | (126%) |